HomeHealthcare & Life SciencesBiotechnology Microbial Transglutaminase Market

LATAM Microbial Transglutaminase Market Size & Outlook, 2025-2033


LATAM Microbial Transglutaminase Market Insights

  • Reed Intelligence analysis indicates that the LATAM Microbial Transglutaminase Market size, which was USD 10.95 Million in 2024, is projected to attain USD 24.78 Million by 2033.
  • The market is expected to register a CAGR of 9.53% over the period 2026–2033.
  • In 2024, Streptomyces Mobaraense emerged as the dominant By Source based on market size.
  • Others is projected to register the fastest growth, positioning it as the most attractive By Source segment over the forecast horizon.

Other Key Findings


  • LATAM represented 8.02% of the global Microbial Transglutaminase Market size in 2024.
  • By 2033, United States is estimated to hold the largest position in the global market in terms of size.
  • Chile is estimated to remain the fastest-growing market in LATAM, advancing to USD 2.2 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 10.95 Million
Market Size In 2033 USD 24.78 Million
Largest segment Streptomyces Mobaraense
Units Revenue in USD Million
CAGR 9.53% (2025-2033)
Segmnetation Covered
LATAM
  1. Brazil
  2. Mexico
  3. Argentina
  4. Colombia
  5. Chile
By Source
  1. Streptomyces Mobaraense
  2. Streptoverticillium Griseocarneum
  3. Streptoverticillium Hygroscopicus
  4. Others
By Form
  1. Powder
  2. Liquid
By End-Use Industry
  1. Food & Beverage
  2. Pharmaceuticals
  3. Cosmetics
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports